Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
41.67
+0.68 (1.66%)
At close: Dec 5, 2025, 4:00 PM EST
42.00
+0.33 (0.79%)
After-hours: Dec 5, 2025, 4:43 PM EST
KNSA Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for KNSA stock ranges from a low of $44 to a high of $60. The average analyst price target of $51.33 forecasts a 23.18% increase in the stock price over the next year.
Price Target: $51.33 (+23.18%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 29, 2025.
Analyst Ratings
The average analyst rating for KNSA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 8 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $45 → $55 | Strong Buy | Maintains | $45 → $55 | +31.99% | Oct 29, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | +19.99% | Oct 17, 2025 |
| Wedbush | Wedbush | Buy Maintains $38 → $44 | Buy | Maintains | $38 → $44 | +5.59% | Oct 13, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +43.99% | Sep 29, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $42 → $45 | Buy | Maintains | $42 → $45 | +7.99% | Sep 25, 2025 |
Financial Forecast
Revenue This Year
688.32M
from 423.24M
Increased by 62.63%
Revenue Next Year
894.30M
from 688.32M
Increased by 29.93%
EPS This Year
1.00
from -0.60
EPS Next Year
1.72
from 1.00
Increased by 72.42%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 710.2M | 990.2M | ||||
| Avg | 688.3M | 894.3M | ||||
| Low | 659.4M | 795.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 67.8% | 43.9% | ||||
| Avg | 62.6% | 29.9% | ||||
| Low | 55.8% | 15.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.22 | 2.55 | ||||
| Avg | 1.00 | 1.72 | ||||
| Low | 0.86 | 1.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 155.5% | ||||
| Avg | - | 72.4% | ||||
| Low | - | 19.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.